Exchange: NASDAQ Sector: Healthcare Industry: Pharmaceutical Retailers
-2.49% $6.26
America/New_York / 25 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 8.80 mill |
EPS: | -17.96 |
P/E: | -0.350 |
Earnings Date: | May 13, 2024 |
SharesOutstanding: | 1.406 mill |
Avg Daily Volume: | 0.438 mill |
RATING 2024-04-25 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Strong Buy | |
P/E: | Neutral | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -0.350 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.05x |
Company: PE -0.350 | industry: PE 7.30 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 2.87 - 9.65 ( +/- 54.12%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-05 | Patel Prashant | Buy | 150 000 | Common stock |
2024-01-05 | Ajjarapu Surendra K | Buy | 150 000 | Common stock |
2022-12-13 | Huffman Janet | Buy | 50 000 | Common stock |
2023-01-16 | Peterson Michael L | Buy | 135 802 | Stock Option |
2023-01-16 | Peterson Michael L | Buy | 100 000 | Common stock |
INSIDER POWER |
---|
100.00 |
Last 90 transactions |
Buy: 1 800 067 | Sell: 2 359 062 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $6.26 (-2.49% ) |
Volume | 0.0203 mill |
Avg. Vol. | 0.438 mill |
% of Avg. Vol | 4.64 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.